Get ready for a slew of diabetes news announcements, because the ADA’s huge annual conference starts today!
I’ll be on an airplane pretty much all day (Friday) heading out to Orlando to cover this conference live, although I must warn you: it’s quite overwhelming. Running around the 450,000 square-foot convention center trying to see every diabetes company represented in the enormous exhibit halls while hundreds of symposia and other talk sessions are happening simultaneously is…
Read more »
By
AmyT on
April 16, 2010
If you can still get excited about diabetes research headlines, then here’s some exciting news coming out of Cambridge, Mass, this week: Tolerx, a life sciences company, has reported they are in Phase 3 clinical trials for a new treatment of type 1 diabetes. If everything goes to plan, a representative of the company says, Tolerx could launch the first-ever offering approved by the FDA to treat the cause of type 1 diabetes. Pretty cool!…
Read more »
The high-powered diabetic cycling group Team Type 1 has once again pulled off a jaw-dropping feat: they’ve somehow caught the attention of 23andMe, one of just three celeb-status companies in the world offering “personal genomics services” — they scan people’s DNA for details on their ancestry and individual health risks — and convinced them to launch a probe into Type 1 and Type 2 diabetes.
This research could provide unprecedented insights into the genes that…
Read more »
By
AmyT on
March 25, 2010
Peter Jones may have a common name, but he’s a rare animal. He’s one of the few academic design experts focusing specifically on the user experience in healthcare. And we are delighted to welcome him this year as one of our expert judges for the 2010 DiabetesMine Design Challenge!
FYI, Peter has a PhD in Design and Innovation Management, and publishes research in organizational behavior, strategic innovation, and human information interaction as a visiting scholar…
Read more »
